Fennec Pharmaceuticals (FRX) News Today C$11.15 0.00 (0.00%) As of 05/23/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock FRX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Q2 EPS Estimate for Fennec Pharmaceuticals Lifted by AnalystFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Investment analysts at HC Wainwright increased their Q2 2025 EPS estimates for shares of Fennec Pharmaceuticals in a research note issued on Tuesday, May 20th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical compaMay 24 at 7:37 AM | marketbeat.comHC Wainwright Analysts Boost Earnings Estimates for TSE:FRXMay 24 at 1:41 AM | americanbankingnews.comHC Wainwright Issues Positive Estimate for TSE:FRX EarningsFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Equities research analysts at HC Wainwright raised their FY2026 earnings estimates for shares of Fennec Pharmaceuticals in a note issued to investors on Tuesday, May 20th. HC Wainwright analyst R. Selvaraju now expects that the biopharmaceuticMay 23 at 8:47 AM | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Reaches New 1-Year High After Insider Buying ActivityMay 21, 2025 | americanbankingnews.comInsider Buying: Fennec Pharmaceuticals Inc. (TSE:FRX) Director Buys 15,000 Shares of StockMay 20, 2025 | insidertrades.comWedbush Lifts Earnings Estimates for Fennec PharmaceuticalsMay 18, 2025 | americanbankingnews.comFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2025 Earnings Call TranscriptMay 14, 2025 | msn.comFennec Pharmaceuticals Inc. (FENC) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comInsider Selling: Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells 10,000 Shares of StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov sold 10,000 shares of the firm's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of C$7.46, for a total transaction of C$74,550.00.April 10, 2025 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Share Price Passes Below 50 Day Moving Average - Should You Sell?Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below Fifty Day Moving Average - Here's WhyApril 2, 2025 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Stock Price Passes Above 50 Day Moving Average - Here's WhyFennec Pharmaceuticals (TSE:FRX) Shares Pass Above 50 Day Moving Average - Time to Sell?March 23, 2025 | marketbeat.comHC Wainwright Analysts Raise Earnings Estimates for TSE:FRXFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Stock analysts at HC Wainwright raised their Q1 2025 earnings per share estimates for Fennec Pharmaceuticals in a research note issued on Tuesday, March 11th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical companMarch 14, 2025 | marketbeat.comResearch Analysts Offer Predictions for TSE:FRX Q1 EarningsFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Research analysts at Wedbush increased their Q1 2025 earnings per share estimates for shares of Fennec Pharmaceuticals in a research report issued on Monday, March 10th. Wedbush analyst D. Nierengarten now anticipates that the biopharmaceuticaMarch 14, 2025 | marketbeat.comWedbush Has Optimistic Outlook of TSE:FRX FY2025 EarningsFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Equities research analysts at Wedbush boosted their FY2025 EPS estimates for Fennec Pharmaceuticals in a report released on Monday, March 10th. Wedbush analyst D. Nierengarten now anticipates that the biopharmaceutical company will earn $0.79March 12, 2025 | marketbeat.comFennec reports Q4 EPS (6c), consensus (13c)March 10, 2025 | markets.businessinsider.comFennec Pharmaceuticals Inc. (TSE:FRX) Director Rostislav Christov Raykov Sells 7,569 SharesFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov sold 7,569 shares of Fennec Pharmaceuticals stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of C$9.71, for a total value of C$73,503.54.March 7, 2025 | marketbeat.comInsider Selling: Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells 7,569 Shares of StockMarch 7, 2025 | insidertrades.comFennec Pharmaceuticals (TSE:FRX) Share Price Crosses Above Fifty Day Moving Average - Time to Sell?Fennec Pharmaceuticals (TSE:FRX) Stock Passes Above Fifty Day Moving Average - What's Next?March 2, 2025 | marketbeat.comInsider Selling: Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells 1,186 Shares of StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Chris Anigeron Rallis sold 1,186 shares of the business's stock in a transaction dated Friday, February 14th. The stock was sold at an average price of C$9.68, for a total transaction of C$11,485.70.February 15, 2025 | marketbeat.comFennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$11,485.70 in StockFebruary 15, 2025 | insidertrades.comFennec Pharmaceuticals (TSE:FRX) Share Price Passes Above 50 Day Moving Average - Should You Sell?Fennec Pharmaceuticals (TSE:FRX) Shares Pass Above Fifty Day Moving Average - Time to Sell?February 13, 2025 | marketbeat.comFennec Pharmaceuticals Inc. (TSE:FRX) Director Rostislav Christov Raykov Sells 2,431 SharesFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov sold 2,431 shares of the firm's stock in a transaction that occurred on Wednesday, February 5th. The stock was sold at an average price of C$9.66, for a total value of C$23,476.17.February 5, 2025 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Share Price Passes Above Fifty Day Moving Average - Should You Sell?Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Above 50-Day Moving Average - Time to Sell?February 1, 2025 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Share Price Crosses Below 50 Day Moving Average - What's Next?Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below 50 Day Moving Average - What's Next?January 24, 2025 | marketbeat.comFennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$87,552.00 in StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov sold 10,000 shares of the firm's stock in a transaction dated Monday, January 6th. The shares were sold at an average price of C$8.76, for a total transaction of C$87,552.00.January 8, 2025 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Stock Price Passes Above Fifty Day Moving Average - Here's What HappenedFennec Pharmaceuticals (TSE:FRX) Shares Cross Above 50-Day Moving Average - Here's WhyJanuary 2, 2025 | marketbeat.comQ4 EPS Estimate for Fennec Pharmaceuticals Raised by AnalystFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Wedbush increased their Q4 2024 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a research report issued on Sunday, December 22nd. Wedbush analyst D. Nierengarten now anticipates that the biopharmaceutical company will post eaDecember 25, 2024 | marketbeat.comWedbush Raises Earnings Estimates for Fennec PharmaceuticalsFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Equities researchers at Wedbush increased their Q3 2025 earnings per share (EPS) estimates for shares of Fennec Pharmaceuticals in a research note issued to investors on Sunday, December 22nd. Wedbush analyst D. Nierengarten now anticipates thDecember 24, 2024 | marketbeat.comRostislav Christov Raykov Acquires 25,000 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) StockDecember 24, 2024 | insidertrades.comFennec Pharmaceuticals Inc. (TSE:FRX) Director Acquires C$96,840.00 in StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov purchased 25,000 shares of the stock in a transaction dated Friday, December 20th. The shares were purchased at an average price of C$3.87 per share, with a total value of C$96,840.00.December 23, 2024 | marketbeat.comFY2024 Earnings Forecast for TSE:FRX Issued By HC WainwrightFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - HC Wainwright lowered their FY2024 EPS estimates for shares of Fennec Pharmaceuticals in a report issued on Tuesday, December 17th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will post earnings per shDecember 19, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Trading Down 0.3% - Time to Sell?Fennec Pharmaceuticals (TSE:FRX) Trading Down 0.3% - Here's WhyDecember 13, 2024 | marketbeat.comInsider Buying: Fennec Pharmaceuticals Inc. (TSE:FRX) Senior Officer Purchases 15,816 Shares of StockNovember 22, 2024 | insidertrades.comFennec Pharmaceuticals (TSE:FRX) Rating Increased to Strong-Buy at StephensStephens upgraded Fennec Pharmaceuticals to a "strong-buy" rating in a research note on Monday.November 20, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Shares Pass Below 50-Day Moving Average - Here's WhyFennec Pharmaceuticals (TSE:FRX) Share Price Crosses Below 50 Day Moving Average - Should You Sell?November 19, 2024 | marketbeat.comWedbush Cuts Earnings Estimates for Fennec PharmaceuticalsFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Stock analysts at Wedbush decreased their FY2025 earnings per share (EPS) estimates for shares of Fennec Pharmaceuticals in a note issued to investors on Thursday, November 7th. Wedbush analyst D. Nierengarten now forecasts that the biopharmacNovember 11, 2024 | marketbeat.comFennec Pharmaceuticals (FENC) Gets a Buy from Craig-HallumNovember 7, 2024 | markets.businessinsider.comFennec Pharmaceuticals (FRX) Scheduled to Post Quarterly Earnings on ThursdayFennec Pharmaceuticals (TSE:FRX) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports.November 1, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Stock Crosses Below 50-Day Moving Average - Time to Sell?Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below Fifty Day Moving Average - Time to Sell?October 29, 2024 | marketbeat.comFennec announces three executive appointmentsOctober 29, 2024 | markets.businessinsider.comCapital One Financial Estimates TSE:FRX Q3 EarningsFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Capital One Financial increased their Q3 2024 earnings estimates for shares of Fennec Pharmaceuticals in a note issued to investors on Wednesday, October 16th. Capital One Financial analyst N. Quibria now forecasts that the biopharmaceutical cOctober 21, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Hits New 52-Week Low - Should You Sell?Fennec Pharmaceuticals (TSE:FRX) Sets New 52-Week Low - What's Next?October 8, 2024 | marketbeat.comRostislav Christov Raykov Sells 2,431 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov sold 2,431 shares of the stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of C$6.67, for a total transaction of C$16,212.34.October 4, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Reaches New 12-Month Low at $7.00Fennec Pharmaceuticals (TSE:FRX) Sets New 52-Week Low at $7.00September 23, 2024 | marketbeat.comFennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$18,115.81 in StockSeptember 7, 2024 | insidertrades.comInsider Selling: Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells 2,431 Shares of StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov sold 2,431 shares of the business's stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of C$7.45, for a total transaction of C$18,115.81.September 6, 2024 | marketbeat.comFennec Pharmaceuticals Inc.September 5, 2024 | wsj.comFennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Below 50-Day Moving Average of $8.25Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below Fifty Day Moving Average of $8.25September 3, 2024 | marketbeat.comCantor Fitzgerald Weighs in on Fennec Pharmaceuticals Inc.'s FY2024 Earnings (TSE:FRX)Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2024 EPS estimates for Fennec Pharmaceuticals in a note issued to investors on Thursday, August 22nd. Cantor Fitzgerald analyst C. Duncan now expects that the biopharmaceutical companAugust 26, 2024 | marketbeat.comFennec Pharmaceuticals Inc (FRX)August 16, 2024 | investing.com Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter. Email Address FRX Media Mentions By Week FRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FRX News Sentiment▼0.910.77▲Average Medical News Sentiment FRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FRX Articles This Week▼131▲FRX Articles Average Week Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SLS News Today TLRY News Today AIM News Today ITH News Today APM News Today CRDL News Today GXE News Today MDNA News Today GPH News Today EQ News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:FRX) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
